The company was founded by four members of the major Italian scientific group specialized in the study of extracellular vesicles in the field of regenerative medicine.


Prof. Giovanni Camussi, MD

Co-founder, Chair, and CSO

Emeritus Professor at University of Turin
45 years of research in nephrology, regenerative medicine, stem cells, and extracellular vesicles

566 publications on peer-reviewed journals
109 h-index score
28 patents


Maria Chiara Deregibus, MD

Co-founder and Scientific Advisor

35 years of research in regenerative medicine, tumor angiogenesis, and extracellular vesicles

83 publications on peer-reviewed journals
48 h-index score
6 patents

Foto Marco Dieci

Marco Dieci

Board Member and Chief Operating Officer

Marco Dieci, master's degree in Chemistry.

He brings over 25 years of management experience in the life science industry, specifically in clinical operations management, pharma business development, and market access.

Former positions:

  • CEO at Holostem
  • Executive Director at the facility of Children Hospital Bambino Gesù in Rome
  • CEO of Xellbiogene, and Operations Director at MolMed


Chiara Gai, PhD

Co-founder and R&D Operation Manager

Expert in regenerative medicine, stem cells, extracellular vesicles, and diabetes

20 publications on peer-reviewed journals
16 h-index score
4 patents submitted


Margherita Pomatto, PhD

Co-founder and R&D Project Manager

Expert in regenerative medicine, stem cells, extracellular vesicles, and oncology

7 publications on peer-reviewed journals
9 h-index score
4 patents submitted


EvoBiotech comes from a research team specialized in the field of extracellular vesicles. Prof. Camussi, active in the biomedical research field of stem cells, has been a pioneer on the international landscape of the research on extracellular vesicles. The first discovery goes back to 2007 when Prof. Camussi and Dr. Deregibus demonstrated that extracellular vesicles act as mediators of the exchange of information between cells.


During the following years, the research team of Prof. Camussi deeply studied mechanisms of action of extracellular vesicles and their role in healthy organisms, tumors, and other pathologies. Among the most interesting properties of extracellular vesicles, and specifically of extracellular vesicles released by stem cells, there are regenerative properties. In fact, extracellular vesicles can enter into cells that are damaged by a pathologic condition (such as ischemia or fibrosis), reprogram the behavior of the cell, and activate processes for the restoration of the damage.

Part of the research activity has been dedicated to the study of the techniques of purification and characterization of extracellular vesicles and of their composition and therapeutic potential.

Prof. Camussi has been for a long time an expert member of the International Society for Extracellular Vesicles (ISEV), the firstborn among international societies of experts in the field of extracellular vesicles.


EvoBiotech is currently incubeted at the "Incubatore d'Imprese dell'Università di Torino - 2i3T SCARL"